000			01785 a2200493 4500
005			20250515224448.0
264		0	_c20100914
008			201009s 0 0 eng d
022			_a1563-5279
024	7		_a10.3109/00207451003797694 _2doi
040			_aNLM _beng _cNLM
100	1		_aGuan, Qiang
245	0	0	_aEffect of cdk5 antagonist on L-dopa-induced dyskinesias in a rat model of Parkinson's disease. _h[electronic resource]
260			_bThe International journal of neuroscience _cJun 2010
300			_a421-7 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aAntiparasitic Agents _xadverse effects
650	0	4	_aCorpus Striatum _xdrug effects
650	0	4	_aCyclin-Dependent Kinase 5 _xantagonists & inhibitors
650	0	4	_aDisease Models, Animal
650	0	4	_aDopamine and cAMP-Regulated Phosphoprotein 32 _xmetabolism
650	0	4	_aDyskinesia, Drug-Induced _xcomplications
650	0	4	_aFemale
650	0	4	_aLevodopa _xadverse effects
650	0	4	_aMale
650	0	4	_aOxidopamine
650	0	4	_aParkinsonian Disorders _xcomplications
650	0	4	_aPhosphorylation _xdrug effects
650	0	4	_aProtein Kinase Inhibitors _xtherapeutic use
650	0	4	_aPurines _xtherapeutic use
650	0	4	_aRandom Allocation
650	0	4	_aRats
650	0	4	_aRats, Sprague-Dawley
650	0	4	_aRoscovitine
650	0	4	_aSeverity of Illness Index
650	0	4	_aTreatment Outcome
700	1		_aLiu, Xueyuan
700	1		_aHe, Yusheng
700	1		_aJin, Lingjing
700	1		_aZhao, Lijuan
773	0		_tThe International journal of neuroscience _gvol. 120 _gno. 6 _gp. 421-7
856	4	0	_uhttps://doi.org/10.3109/00207451003797694 _zAvailable from publisher's website
999			_c19856721 _d19856721